Positron emission tomography in oncology

W. R. Hendee; G. M. Bohigian; E. H. Estes; I. R. Friedlander; W. R. Kennedy; J. H. Moxley; P. J. Numann; P. S. Salva; W. C. Scott; J. H. Skom; R. M. Steinhilber; J. P. Strong; H. H. Wagner; W. T. McGivney; J. S. Favler; E. J. Hoffman; S. M. Larson; H. R. Schelbert; M. Schwaiger

doi:10.1001/jama.259.14.2126

Positron emission tomography in oncology

W. R. Hendee, G. M. Bohigian, E. H. Estes, I. R. Friedlander, W. R. Kennedy, J. H. Moxley, P. J. Numann, P. S. Salva, W. C. Scott, J. H. Skom, R. M. Steinhilber, J. P. Strong, H. H. Wagner, W. T. McGivney, J. S. Favler, E. J. Hoffman, S. M. Larson, H. R. Schelbert, M. Schwaiger

Neurology

Research output: Contribution to journal › Review article › peer-review

Abstract

This report describes the current and potential uses of positron emission tomography in clinical medicine and research related to oncology. Assessment will be possible of metabolism and physiology of tumors and their effects on adjacent tissues. Specific probes are likely to be developed for target sites on tumors, including monoclonal antibodies and specific growth factors that recognize tumors. To date, most oncological applications of positron emission tomography tracers have been qualitative; in future, quantitative metabolic measurements should aid in the evaluation of tumor biology and response to treatment.

Original language	English (US)
Pages (from-to)	2126-2131
Number of pages	6
Journal	Journal of the American Medical Association
Volume	259
Issue number	14
DOIs	https://doi.org/10.1001/jama.259.14.2126
State	Published - Apr 29 1988

Publisher link

10.1001/jama.259.14.2126

Find It

Find It at U of M Libraries

Cite this

Hendee, W. R., Bohigian, G. M., Estes, E. H., Friedlander, I. R., Kennedy, W. R., Moxley, J. H., Numann, P. J., Salva, P. S., Scott, W. C., Skom, J. H., Steinhilber, R. M., Strong, J. P., Wagner, H. H., McGivney, W. T., Favler, J. S., Hoffman, E. J., Larson, S. M., Schelbert, H. R., & Schwaiger, M. (1988). Positron emission tomography in oncology. Journal of the American Medical Association, 259(14), 2126-2131. https://doi.org/10.1001/jama.259.14.2126

Hendee, WR, Bohigian, GM, Estes, EH, Friedlander, IR, Kennedy, WR, Moxley, JH, Numann, PJ, Salva, PS, Scott, WC, Skom, JH, Steinhilber, RM, Strong, JP, Wagner, HH, McGivney, WT, Favler, JS, Hoffman, EJ, Larson, SM, Schelbert, HR & Schwaiger, M 1988, 'Positron emission tomography in oncology', Journal of the American Medical Association, vol. 259, no. 14, pp. 2126-2131. https://doi.org/10.1001/jama.259.14.2126

@article{b20ce9759aab46c892ba94380d1a0ea4,

title = "Positron emission tomography in oncology",

abstract = "This report describes the current and potential uses of positron emission tomography in clinical medicine and research related to oncology. Assessment will be possible of metabolism and physiology of tumors and their effects on adjacent tissues. Specific probes are likely to be developed for target sites on tumors, including monoclonal antibodies and specific growth factors that recognize tumors. To date, most oncological applications of positron emission tomography tracers have been qualitative; in future, quantitative metabolic measurements should aid in the evaluation of tumor biology and response to treatment.",

author = "Hendee, {W. R.} and Bohigian, {G. M.} and Estes, {E. H.} and Friedlander, {I. R.} and Kennedy, {W. R.} and Moxley, {J. H.} and Numann, {P. J.} and Salva, {P. S.} and Scott, {W. C.} and Skom, {J. H.} and Steinhilber, {R. M.} and Strong, {J. P.} and Wagner, {H. H.} and McGivney, {W. T.} and Favler, {J. S.} and Hoffman, {E. J.} and Larson, {S. M.} and Schelbert, {H. R.} and M. Schwaiger",

year = "1988",

month = apr,

day = "29",

doi = "10.1001/jama.259.14.2126",

language = "English (US)",

volume = "259",

pages = "2126--2131",

journal = "Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "14",

}

TY - JOUR

T1 - Positron emission tomography in oncology

AU - Hendee, W. R.

AU - Bohigian, G. M.

AU - Estes, E. H.

AU - Friedlander, I. R.

AU - Kennedy, W. R.

AU - Moxley, J. H.

AU - Numann, P. J.

AU - Salva, P. S.

AU - Scott, W. C.

AU - Skom, J. H.

AU - Steinhilber, R. M.

AU - Strong, J. P.

AU - Wagner, H. H.

AU - McGivney, W. T.

AU - Favler, J. S.

AU - Hoffman, E. J.

AU - Larson, S. M.

AU - Schelbert, H. R.

AU - Schwaiger, M.

PY - 1988/4/29

Y1 - 1988/4/29

N2 - This report describes the current and potential uses of positron emission tomography in clinical medicine and research related to oncology. Assessment will be possible of metabolism and physiology of tumors and their effects on adjacent tissues. Specific probes are likely to be developed for target sites on tumors, including monoclonal antibodies and specific growth factors that recognize tumors. To date, most oncological applications of positron emission tomography tracers have been qualitative; in future, quantitative metabolic measurements should aid in the evaluation of tumor biology and response to treatment.

AB - This report describes the current and potential uses of positron emission tomography in clinical medicine and research related to oncology. Assessment will be possible of metabolism and physiology of tumors and their effects on adjacent tissues. Specific probes are likely to be developed for target sites on tumors, including monoclonal antibodies and specific growth factors that recognize tumors. To date, most oncological applications of positron emission tomography tracers have been qualitative; in future, quantitative metabolic measurements should aid in the evaluation of tumor biology and response to treatment.

UR - http://www.scopus.com/inward/record.url?scp=0023851494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023851494&partnerID=8YFLogxK

U2 - 10.1001/jama.259.14.2126

DO - 10.1001/jama.259.14.2126

M3 - Review article

C2 - 3279241

SN - 0098-7484

VL - 259

SP - 2126

EP - 2131

JO - Journal of the American Medical Association

JF - Journal of the American Medical Association

IS - 14

ER -

Positron emission tomography in oncology

Abstract

Publisher link

Find It

Other files and links

Fingerprint

Cite this